NanoString Technologies Appoints Kirk Malloy, Ph.D. to Board of Directors
SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Kirk Malloy, Ph.D. to the company’s Board of Directors, effective September 12, 2016. The Board now consists of seven members.
Dr. Malloy is a senior healthcare executive with more than 20 years of leadership in life science tools, applied markets and molecular diagnostics. He is currently founder and principal at BioAdvisors, LLC where he provides strategic consulting services to life science, genomic and diagnostic companies. His previous experience includes a 13-year career at Illumina, Inc., where he was most recently Senior Vice President and General Manager of Life Sciences & Applied Markets. Prior to joining Illumina, Dr. Malloy served as Director of Technical Support at Biosite, Inc. where he helped build their point-of-care cardiovascular diagnostics test business. Dr. Malloy also held various management rol

